SCHEMBL20457805

SCHEMBL20457805

CN/C=N\c1c(C)oc2ccccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.39
▸ MAPT P10636 4/20 0.39
▸ CA2 P00918 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CYP2C19 P33261 6/20 0.36
▸ EYA3 Q99504 2/20 0.36
▸ ALDH1A1 P00352 3/20 0.34
▸ MAOB P27338 1/20 0.34
▸ POLB P06746 1/20 0.34
▸ HPGD P15428 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ GLA P06280 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ PGAM1 P18669 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ CASP1 P29466 1/20 0.33
▸ CASP7 P55210 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9506685 0.76 CYP2C19 (0.42) KDM4EMAPTCA2CYP2C19EYA3
SCHEMBL9506686 0.76 CYP2C19 (0.42) KDM4EMAPTCA2CYP2C19EYA3
SCHEMBL6594750 0.69 CYP2C19 (0.38) KDM4EMAPTCA2CYP2C19EYA3
SCHEMBL183071 0.65 ALDH2 (0.52) KDM4EMAPTCA2L3MBTL1CYP2C19
SCHEMBL30028309 0.65 ALDH2 (0.52) KDM4EMAPTCA2L3MBTL1CYP2C19
SCHEMBL13241355 0.65 CYP2C9 (0.68) KDM4EMAPTL3MBTL1ALDH1A1POLB
SCHEMBL11210021 0.65 CYP2C9 (0.68) KDM4EMAPTL3MBTL1ALDH1A1POLB
SCHEMBL11531465 0.65 CYP2C9 (0.68) KDM4EMAPTL3MBTL1ALDH1A1POLB
SCHEMBL9669090 0.63 KDM4E (0.55) KDM4EMAPTCA2L3MBTL1CYP2C19
SCHEMBL1253476 0.63 CA2 (0.62) KDM4EMAPTCA2CYP2C19EYA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10040794-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2018-08-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10040794-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNE2, CRY2 KDM4E 2699/4885MAPT 1482/4885CA2 3392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback